Sagent

Sagent Pharmaceuticals focuses on the development and commercialization of injectable pharmaceutical products for cancer, oncology and urology.

Business Model:

Revenue: $297.8M

Employees: 201-500

Rankings

Detailed Sagent Information

Sagent was acquired by Nichi-Iko Pharmaceutical.
The acquisition happend on 2016-07-11.
Details of the transaction were not public

Geographic Data

Sagent headquarters map

Address: 1901 N Roselle Rd

City: Schaumburg

State: IL

Zip: 60195

Country: US

Financial Info

Stage:

series b

Raised Last:

$40M

Raised Total:

$153M

Metrics

1,260,745Website Global Rank

19,890Website Monthly Traffic

Twitter Followers

Description

Sagent Pharmaceuticals focuses on the development and commercialization of injectable pharmaceutical products for cancer, oncology and urology.

Contact Phone:
+18479081600

Contact Email:

Sagent went public on 4/19/2011 on the NASDAQ

Listed Exchange:
NASDAQ

IPO Date:
4/19/2011

Ticker Symbol:
SGNT

IPO Price:
$16/share

Amount Raised:
$92M

Live

Opened: -/share

EBITDA -
Total Cash -
Total Debt -
Total Revenue -
Total Profit (Gross) -
PE Ratio -
Announced Date Company Transaction Money Raised
Announced Date Name Price
10/2014 Omega Laboratories

Employee Departments

Employee States

Uniview Singapore VEID Logo
Uniview Singapore VEID
Revenue: 0 - 100000
Employees:
Industry: Software
Details
Konkuk University Medical Center Logo
Konkuk University Medical Center
Revenue: 0 - 100000
Employees: 51 - 500
Industry: Education
Details
Daemon Technologies Logo
Daemon Technologies
Revenue: 0 - 100000
Employees: 1 - 10
Industry: Blockchain
Details
Ace International Trade Logo
Ace International Trade
Revenue: 0 - 100000
Employees: 11 - 50
Industry: Industrial
Details
An Hòa Communications Logo
An Hòa Communications
Revenue: 0 - 100000
Employees: 1 - 10
Industry: Advertising
Details

You know, we could be doing all this for you..

CoBee's Logo

Be ahead of your competition

  • Realtime intelligence
  • Automated contact tracking
  • Unmatched insights
  • Eliminate manual research